6^th International Conference on Physical and Theoretical Chemistry March 18-19, 2020 Amsterdam, Netherlands

Drug Design and Drug Discovery

\r\n  play an important role in our world, not only as effective substances for the prevention, diagnosis and treatment of disease, but also to improve “quality of life”; enabling people to live with a disease as appropriate for their social and cultural background. The process of the design/discovery of drugs typically involves understanding the character of targets (e.g. enzyme, cell, tissues, etc) related to the disease, setting-up the concept of drug design, providing lead compounds (via traditional medicines, natural products, biological macromolecules, compound libraries, computational chemistry, etc.), and design and lead optimisation by means of analysing structure-activity-relationships. Computer-aided  methods have played a major role in the development of therapeutically important small molecules for over three decades. These methods are broadly classified as either structure-based or ligand-based methods. Structure-based methods are in principle analogous to high-throughput screening in that both target and ligand structure information is imperative. Structure-based approaches include ligand docking, pharmacophore, and ligand design methods.

\r\n

• Bio isostere
• Bioinformatics
• Pharmacognosy
• Drug metabolism
• Cheminformatics
• Pharmacogenetics
• Drug development
• Drug development

Recommended Sessions

Related Journals

Are you interested in